Literature DB >> 10968563

Determinants of the pathogenicity of man-made vitreous fibers (MMVF).

G Oberdörster1.   

Abstract

INTRODUCTION AND
OBJECTIVES: A number of man-made vitreous fibers (MMVF) have been developed over the years to replace asbestos fibres in its uses as insulating material. Concerns have been raised that these man-made fibers may also pose a significant health hazard when inhaled during their manufacture and application. As will be discussed in this brief overview, dose, dimension and durability of fibrous particles are key parameters with respect to the induction of adverse pulmonary effects, including carcinogenicity as well as non-cancer effects. In particular, fiber biopersistence plays a most important role for pulmonary pathogenicities, and consequently biopersistence receives greatest attention in the search of new fibrous materials. METHODS AND
RESULTS: Tests to evaluate fiber biopersistence include the administration of fibers by a short-term inhalation (5 days) or intratracheal instillation into rats. Advantages of the inhalation methodology include the even distribution throughout the lung administered by a physiological process. A disadvantage of this method is the limited respirability of long fibers in the rat whereas they are well respirable by humans. Such long fibers ( > 20 microm) have the greatest potential for tumorigenicity and need special consideration in connection with the evaluation of fiber biopersistence. Enrichment of the inhaled aerosol by these long fibers needs to be considered in order to deposit enough of them in the lower respiratory tract of the rat. In contrast, the advantage of the instillation technique is that these long fibers can be delivered to the lung. However, the major disadvantages of intratracheal instillations are the potential of the administered fibers to form clumps and aggregates in the airways and the induction of a major inflammatory response when high-bolus doses are administered. This could influence fiber dissolution in the lungs significantly.
CONCLUSIONS: At the same delivered lung dose, a fiber of low biopersistency has the least effect and is, therefore, less likely to induce lung or pleural tumors even under chronic exposure conditions. Respective animal studies with more fibers of different biopersistence have confirmed this general principle. It is very important that, when evaluating and interpreting fiber effects observed in experimental animals, species differences with respect to respirability, lung retention and mechanisms of responses are considered.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10968563     DOI: 10.1007/pl00014628

Source DB:  PubMed          Journal:  Int Arch Occup Environ Health        ISSN: 0340-0131            Impact factor:   3.015


  16 in total

1.  Separation and characterization of respirable amphibole fibers from Libby, Montana.

Authors:  James S Webber; David J Blake; Tony J Ward; Jean C Pfau
Journal:  Inhal Toxicol       Date:  2008-06       Impact factor: 2.724

Review 2.  Pulmonary endpoints (lung carcinomas and asbestosis) following inhalation exposure to asbestos.

Authors:  Brooke T Mossman; Morton Lippmann; Thomas W Hesterberg; Karl T Kelsey; Aaron Barchowsky; James C Bonner
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2011       Impact factor: 6.393

Review 3.  Applying Existing Particle Paradigms to Inhaled Microplastic Particles.

Authors:  Stephanie Wright; Paul J A Borm
Journal:  Front Public Health       Date:  2022-05-30

Review 4.  Non-neoplastic and neoplastic pleural endpoints following fiber exposure.

Authors:  V Courtney Broaddus; Jeffrey I Everitt; Brad Black; Agnes B Kane
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2011       Impact factor: 6.393

5.  Durability and inflammogenic impact of carbon nanotubes compared with asbestos fibres.

Authors:  Megan J Osmond-McLeod; Craig A Poland; Fiona Murphy; Lynne Waddington; Howard Morris; Stephen C Hawkins; Steve Clark; Rob Aitken; Maxine J McCall; Ken Donaldson
Journal:  Part Fibre Toxicol       Date:  2011-05-13       Impact factor: 9.400

6.  Nanoparticles - known and unknown health risks.

Authors:  Peter Hm Hoet; Irene Brüske-Hohlfeld; Oleg V Salata
Journal:  J Nanobiotechnology       Date:  2004-12-08       Impact factor: 10.435

Review 7.  Dissolution and biodurability: Important parameters needed for risk assessment of nanomaterials.

Authors:  Wells Utembe; Kariska Potgieter; Aleksandr Byron Stefaniak; Mary Gulumian
Journal:  Part Fibre Toxicol       Date:  2015-04-28       Impact factor: 9.400

8.  Mesothelioma: Do asbestos and carbon nanotubes pose the same health risk?

Authors:  Marie-Claude F Jaurand; Annie Renier; Julien Daubriac
Journal:  Part Fibre Toxicol       Date:  2009-06-12       Impact factor: 9.400

9.  Use of silver nanowires to determine thresholds for fibre length-dependent pulmonary inflammation and inhibition of macrophage migration in vitro.

Authors:  Anja Schinwald; Tanya Chernova; Ken Donaldson
Journal:  Part Fibre Toxicol       Date:  2012-12-02       Impact factor: 9.400

10.  A biopersistence study following exposure to chrysotile asbestos alone or in combination with fine particles.

Authors:  D M Bernstein; K Donaldson; U Decker; S Gaering; P Kunzendorf; J Chevalier; S E Holm
Journal:  Inhal Toxicol       Date:  2008-09       Impact factor: 2.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.